Chardan Capital Maintains Buy on EyePoint, Raises Price Target to $65

Benzinga Newsdesk www.benzinga.com Positive 80.4%

Neg 0% Neu 0% Pos 80.4%

Chardan Capital analyst Andreas Argyrides maintains EyePoint (NASDAQ:EYPT) with a Buy and raises the price target from $29 to $65.